What evidence exists to support antiviral treatment in children with chronic hepatitis B?
Antivir Ther
; 19(3): 225-7, 2014.
Article
in En
| MEDLINE
| ID: mdl-24192644
ABSTRACT
Many questions are unanswered on the optimal management of chronically HBV-infected children. Chronic hepatitis B is generally a mild disease in children; however, response to therapy is partial and limited to specific subgroups, and available drugs have no proven advantage on long-term course of disease versus no treatment, and are hampered by numerous limitations. Studies on the natural history of chronic hepatitis B and the long-term results of the therapeutic schedules adopted so far should be critically appraised. A balance between the potential benefits of the treatment and its side effects, and the spontaneous course of the disease left untreated should be made.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
DNA, Viral
/
Hepatitis B virus
/
Disease Management
/
Hepatitis B, Chronic
/
Hepatitis B Antibodies
Limits:
Child
/
Humans
Language:
En
Journal:
Antivir Ther
Journal subject:
TERAPIA POR MEDICAMENTOS
/
VIROLOGIA
Year:
2014
Type:
Article
Affiliation country:
Italy